M. Sánchez Ronco

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

Miquel Tarón, Rafael Rosell, Enriqueta Felip et al. · Human Molecular Genetics · 2004 · 305 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The Prognostic Value of BRCA1 mRNA Expression Levels Following Neoadjuvant Chemotherapy in Breast Cancer

Mireia Margelí Vila, Beatriz Cirauqui, Eva Castellà et al. · PLoS ONE · 2010 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +16

3BA A phase II trial of erlotinib (E) and bevacizumab (B) in patients with advanced non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations with and without T790M mutation. The Spanish Lung Cancer Group (SLCG) and the European Thoracic Oncology Platform (ETOP) BELIEF trial

R. Stahel, Urania Dafni, Oliver Gautschi et al. · European Journal of Cancer · 2015 · 28 citations

Medicine, Oncology, Pharmacology +16